Kronox Lab Sciences Ltd

KRONOX Lab Sciences Limited informed the National Stock Exchange of India Limited and BSE Limited that Wednesday, September 09, 2026, has been set as the record date for determining shareholders eligible to receive a final dividend of Rs 0.50 per equity share of Rs 10 each for the financial year ended March 31, 2026, following a board recommendation in May 2026.

Indo Borax and Chemicals Limited has initiated a public offer, or Open Offer, to acquire shares of Kronox Lab Sciences Limited following the Acquirer's acquisition of a substantial stake, triggering requirements under Indian takeover regulations. The announcement was made on August 20, 2026, with Zenrock Chemicals Private Limited acting as the Promoter Authorised Representative for Indo Borax. Key details of the offer, including the price and tendering period, will be disclosed in a Detailed Public Statement expected to be published within five working days, by August 28, 2026. Kronox Lab Sciences Limited is obligated to maintain normal business operations and adhere to specific restrictions outlined by SEBI, including limitations on asset sales, borrowing, and share issuances, while also facilitating the Open Offer process with the assistance of IIFL Capital Services Limited.

Indo Borax and Chemicals Limited, alongside Promoter Actioning Company Zenrock Chemicals Private Limited, has launched an Open Offer to acquire shares from public shareholders of Kronox Lab Sciences Limited, a company listed on the BSE and NSE. This action follows a Share Purchase Agreement where Indo Borax will acquire a 74.21% stake from existing shareholders, triggering the Open Offer as a regulatory requirement. The Open Offer seeks to acquire 95,70,000 shares, representing 25.79% of the Voting Share Capital, and is not subject to a minimum acceptance level. A Detailed Public Statement, including the offer price, will be released within five working days, by August 28, 2026. IIFL Capital Services Limited is managing the Open Offer, which is compliant with SEBI (SAST) Regulations, and the Acquirer will ensure Kronox maintains the required minimum public shareholding.

KRONOX Lab Sciences Limited informed the National Stock Exchange of India Limited and BSE Limited that its register of members and share transfer books will be closed from September 10, 2026, to September 16, 2026, for the purpose of paying a final dividend for the financial year 2025-26, contingent upon approval at the company’s 17th Annual General Meeting scheduled for September 16, 2026.

KRONOX Lab Sciences Limited informed the National Stock Exchange of India Limited and BSE Limited that its register of members and share transfer books will be closed from September 10, 2026, to September 16, 2026, for the purpose of paying a final dividend for the financial year 2025-26, contingent upon approval at the company’s 17th Annual General Meeting scheduled for September 16, 2026.

KRONOX Lab Sciences Limited will hold a board meeting on Wednesday, August 12, 2026, to consider and approve the unaudited standalone financial results for the quarter ended June 30, 2026, the company said in a filing. The trading window for the company's securities will be closed for directors, officers, and designated employees from July 1, 2026, and will remain closed until 48 hours after the financial results are declared.

Kronox Lab Sciences announced that the Board of Directors of the Company at its meeting held on 21 May 2026, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 5%) , subject to the approval of the shareholders.

Net profit of Kronox Lab Sciences rose 26.58% to Rs 8.00 crore in the quarter ended March 2026 as against Rs 6.32 crore during the previous quarter ended March 2025. Sales remain constant at Rs 26.13 crore in the quarter ended March 2026 and also during the previous quarter ended March 2025. For the full year,net profit rose 8.60% to Rs 27.66 crore in the year ended March 2026 as against Rs 25.47 crore during the previous year ended March 2025. Sales rose 1.03% to Rs 101.22 crore in the year ended March 2026 as against Rs 100.19 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales26.1326.13 0 101.22100.19 1 OPM %36.3929.70 -33.8633.06 - PBDT11.628.67 34 39.3535.65 10 PBT10.968.32 32 37.3034.27 9 NP8.006.32 27 27.6625.47 9 Powered by Capital Market - Live

Kronox Lab Sciences will hold a meeting of the Board of Directors of the Company on 21 May 2026.

Kronox Lab Sciences will hold a meeting of the Board of Directors of the Company on 20 May 2026.